Literature DB >> 12463614

Recent advances in peripheral angioplasty and stenting.

Peter Faries1, Nicholas J Morrissey, Victoria Teodorescu, Edwin C Gravereaux, James A Burks, Alfio Carroccio, K Craig Kent, Larry H Hollier, Michael L Marin.   

Abstract

Utilization of percutaneous interventions for arterial and venous occlusive lesions continue to increase. With the progression of the technology supporting these therapeutic measures, the results of these interventions may be expected to improve. In general, a comparison of techniques for revascularization demonstrates similar initial technical success rates for surgery and percutaneous transluminal angioplasty. Angioplasty is often associated with lower procedural morbidity and mortality rates. Conversely, surgery frequently provides greater long-term patency. Late failure of percutaneous therapies may often be treated successfully with reintervention, however. The continued accumulation of experience with PTA and stenting will ultimately define its role in the management of occlusive disease.

Entities:  

Mesh:

Year:  2002        PMID: 12463614     DOI: 10.1177/000331970205300601

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  3 in total

1.  A novel flexible, retrievable endovascular stent system for small-vessel anatomy: preliminary in vivo data.

Authors:  Arnd Doerfler; Wolfgang P H Becker; Isabel Wanke; Sophia L Goericke; K M Mueller; Nina Blechschmid; Achim Flesser; Hermann Monstadt; Michael Forsting
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

2.  Percutaneous transluminal angioplasty of an occluded surgical splenorenal shunt in a 4-year-old child after liver transplantation.

Authors:  Ethan Yussim; Rivka Shapiro; Eytan Mor; Alexander Belenky; Eli Atar
Journal:  Pediatr Radiol       Date:  2005-01-15

3.  Endovascular Versus Open Revascularization for Peripheral Arterial Disease.

Authors:  Jason T Wiseman; Sara Fernandes-Taylor; Sandeep Saha; Jeffrey Havlena; Paul J Rathouz; Maureen A Smith; K Craig Kent
Journal:  Ann Surg       Date:  2017-02       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.